UVA Health researchers have joined a new international consortium that will work to understand how climate change could affect dangerous diarrheal diseases, a leading cause of death for children under 5 years old.
Adding Isatuximab to Standard Backbone Improves Outcomes in Multiple Myeloma
CHICAGO — Combining the anti-CD38 monoclonal antibody isatuximab (Sarclisa) with the standard backbone of bortezomib (Velcade), lenalidomide (Revlimid), and dexamethasone (VRd) significantly improved outcomes in